Refer to the relevant ClinicalTrials.gov or EudraCT entry for your study for further detail
Over time, this shifts liver metabolism away from fat storage toward fat utilization, gradually depleting accumulated triglycerides within liver cells
Glucagon-Like Peptide 1 Receptor Agonist Discontinuation and Risks of Major Adverse Cardiovascular Events in Adults With Type 2 Diabetes: Target Trial Emulation
One example escalation schedule observed in Phase 2 obesity trials proceeded broadly as follows: Weeks 14: 2 mg once weekly (initiation phase) Weeks 58: 4 mg once weekly Weeks 912: 8 mg once weekly Weeks 13 onwards: Up to 12 mg once weekly (the maximum dose explored in Phase 2 trials) This is an illustrative example only
NHS guidance on disposing of unwanted medicines is available at nhs.uk Sharps disposal any needles or syringes used in reconstitution or administration must be placed in an approved sharps bin
Second, it has been approved to reduce the risk of major adverse cardiovascular events (MACE), including death, heart attack, and stroke, in adults with established cardiovascular disease who also have obesity or overweight
